3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
12
Neoplasms
7
Breast Neoplasms
4
Hypogonadism
3
Eunuchism
3
Testicular Neoplasms
2
Polycystic Ovary Syndrome
2
Obesity
2
Metabolic Syndrome
2
Fatigue
2
Dyspareunia
2
Vaginitis
1
Sleep Apnea, Obstructive
1
Sleep Apnea Syndromes
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Non-alcoholic Fatty Liver Disease
1
Neoplasm Metastasis
1
Muscle Weakness
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Metabolic Diseases
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Infertility
1
Hot Flashes
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Interventions
Cyclophosphamide
22
Trastuzumab
16
Paclitaxel
15
Radiotherapy
13
Docetaxel
13
Capecitabine
11
Doxorubicin
10
Taxes
9
Lapatinib
9
Carboplatin
8
Tamoxifen
7
Immunohistochemistry
7
Biopsy
7
Albumin-Bound Paclitaxel
7
Magnetic Resonance Spectroscopy
6
Fluorodeoxyglucose F18
6
Chemotherapy, Adjuvant
6
Immunoenzyme Techniques
5
Gemcitabine
5
Flow Cytometry
5
Bevacizumab
5
sargramostim
4
Vinorelbine
4
Letrozole
4
Irinotecan
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Filgrastim
4
Everolimus
4
Erlotinib Hydrochloride
4
Cisplatin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Breast Neoplasms, Male
×
Testosterone
×
Clear all
NCT05156606
2024-08-09
T&T
University Medical Center Groningen
Phase NA
Terminated
5 enrolled